Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1002/art.39269

Type

Journal article

Journal

Arthritis & rheumatology (Hoboken, N.J.)

Publication Date

09/2015

Volume

67

Pages

2283 - 2291

Addresses

Kennedy Institute of Rheumatology and University of Oxford, Oxford, UK.

Keywords

Humans, Arthritis, Rheumatoid, Angiogenesis Inhibitors, Tumor Necrosis Factor-alpha, Receptors, Tumor Necrosis Factor, Type I, Antirheumatic Agents, Interleukin-17, Drug Therapy, Combination, Rheumatology, Drug Discovery, Molecular Targeted Therapy